α-synuclein (αS) is a small protein that self-aggregates into α-helical oligomer species and subsequently into larger insoluble amyloid fibrils that accumulate in intraneuronal inclusions during the development of Parkinson's disease. Toxicity of αS oligomers and fibrils has been long debated and more recent data are suggesting that both species can induce neurodegeneration. However while most of these data are based on differences in structure between oligomer and aggregates, often preassembled in vitro, the in vivo situation might be more complex and subcellular locations where αS species accumulate, rather than their conformation, might contribute to enhanced toxicity. In line with this observation, we have shown that αS oligomers and aggregates are associated with the endoplasmic reticulum/microsomes (ER/M) membrane in vivo and how accumulation of soluble αS oligomers at the ER/M level precedes neuronal degeneration in a mouse model of α-synucleinopathies. In this paper we took a further step, investigating the biochemical and functional features of αS species associated with the ER/M membrane. We found that by comparison with non-microsomal associated αS (P10), the ER/M-associated αS pool is a unique population of oligomers and aggregates with specific biochemical traits such as increased aggregation, N- and C-terminal truncations and phosphorylation at serine 129. Moreover, when administered to murine primary neurons, ER/M-associated αS species isolated from diseased A53T human αS transgenic mice induced neuronal changes in a time- and dose-dependent manner. In fact the addition of small amounts of ER/M-associated αS species from diseased mice to primary cultures induced the formation of beads-like structures or strings of fibrous αS aggregates along the neurites, occasionally covering the entire process or localizing at the soma level. By comparison treatment with P10 fractions from the same diseased mice resulted in the formation of scarce and small puncta only when administered at high amount. Moreover, increasing the amount of P100/M fractions obtained from diseased and, more surprisingly, from presymptomatic mice induced a significant level of neuronal death that was prevented when neurons were treated with ER/M fractions immunodepleted of αS high molecular weight (HMW) species. These data provide the first evidence of the existence of two different populations of αS HMW species in vivo, putting the spotlight on the association to ER/M membrane as a necessary step for the acquisition of αS toxic features.

alpha-synuclein (alpha S) is a small protein that self-aggregates into a-helical oligomer species and subsequently into larger insoluble amyloid fibrils that accumulate in intraneuronal inclusions during the development of Parkinson's disease. Toxicity of alpha S oligomers and fibrils has been long debated and more recent data are suggesting that both species can induce neurodegeneration. However while most of these data are based on differences in structure between oligomer and aggregates, often preassembled in vitro, the in vivo situation might be more complex and subcellular locations where alpha S species accumulate, rather than their conformation, might contribute to enhanced toxicity. In line with this observation, we have shown that alpha S oligomers and aggregates are associated with the endoplasmic reticulum/microsomes (ER/M) membrane in vivo and how accumulation of soluble alpha S oligomers at the ER/M level precedes neuronal degeneration in a mouse model of alpha-synucleinopathies. In this paper we took a further step, investigating the biochemical and functional features of alpha S species associated with the ER/M membrane. We found that by comparison with non-microsomal associated alpha S (P10), the ER/M-associated alpha S pool is a unique population of oligomers and aggregates with specific biochemical traits such as increased aggregation, N- and C-terminal truncations and phosphorylation at serine 129. Moreover, when administered to murine primary neurons, ER/M-associated alpha S species isolated from diseased A53T human alpha S transgenic mice induced neuronal changes in a time- and dose-dependent manner. In fact the addition of small amounts of ER/M-associated alpha S species from diseased mice to primary cultures induced the formation of beads-like structures or strings of fibrous alpha S aggregates along the neurites, occasionally covering the entire process or localizing at the soma level. By comparison treatment with P10 fractions from the same diseased mice resulted in the formation of scarce and small puncta only when administered at high amount. Moreover, increasing the amount of P100/M fractions obtained from diseased and, more surprisingly, from presymptomatic mice induced a significant level of neuronal death that was prevented when neurons were treated with ER/M fractions immunodepleted of alpha S high molecular weight (HMW) species. These data provide the first evidence of the existence of two different populations of alpha S HMW species in vivo, putting the spotlight on the association to ER/M membrane as a necessary step for the acquisition of alpha S toxic features.

Toxic properties of microsome-associated alpha-synuclein species in mouse primary neurons

Colla, Emanuela
;
RICCI, ALESSIO;Rizzi, Caterina;ROTA, Lucia;Carucci, Nicola;Gobbo, Francesco;Capsoni, Simona;Cattaneo, Antonino
2018

Abstract

alpha-synuclein (alpha S) is a small protein that self-aggregates into a-helical oligomer species and subsequently into larger insoluble amyloid fibrils that accumulate in intraneuronal inclusions during the development of Parkinson's disease. Toxicity of alpha S oligomers and fibrils has been long debated and more recent data are suggesting that both species can induce neurodegeneration. However while most of these data are based on differences in structure between oligomer and aggregates, often preassembled in vitro, the in vivo situation might be more complex and subcellular locations where alpha S species accumulate, rather than their conformation, might contribute to enhanced toxicity. In line with this observation, we have shown that alpha S oligomers and aggregates are associated with the endoplasmic reticulum/microsomes (ER/M) membrane in vivo and how accumulation of soluble alpha S oligomers at the ER/M level precedes neuronal degeneration in a mouse model of alpha-synucleinopathies. In this paper we took a further step, investigating the biochemical and functional features of alpha S species associated with the ER/M membrane. We found that by comparison with non-microsomal associated alpha S (P10), the ER/M-associated alpha S pool is a unique population of oligomers and aggregates with specific biochemical traits such as increased aggregation, N- and C-terminal truncations and phosphorylation at serine 129. Moreover, when administered to murine primary neurons, ER/M-associated alpha S species isolated from diseased A53T human alpha S transgenic mice induced neuronal changes in a time- and dose-dependent manner. In fact the addition of small amounts of ER/M-associated alpha S species from diseased mice to primary cultures induced the formation of beads-like structures or strings of fibrous alpha S aggregates along the neurites, occasionally covering the entire process or localizing at the soma level. By comparison treatment with P10 fractions from the same diseased mice resulted in the formation of scarce and small puncta only when administered at high amount. Moreover, increasing the amount of P100/M fractions obtained from diseased and, more surprisingly, from presymptomatic mice induced a significant level of neuronal death that was prevented when neurons were treated with ER/M fractions immunodepleted of alpha S high molecular weight (HMW) species. These data provide the first evidence of the existence of two different populations of alpha S HMW species in vivo, putting the spotlight on the association to ER/M membrane as a necessary step for the acquisition of alpha S toxic features.
2018
Settore BIO/09 - Fisiologia
Aggregates; Endoplasmic reticulum; Microsomes; Neurodegeneration; Oligomers; Parkinson's disease; α-Synuclein
File in questo prodotto:
File Dimensione Formato  
Colla Neurobiol disease 2017.pdf

accesso aperto

Descrizione: Articolo principale
Tipologia: Published version
Licenza: Creative Commons
Dimensione 1.68 MB
Formato Adobe PDF
1.68 MB Adobe PDF

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11384/68865
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 21
  • ???jsp.display-item.citation.isi??? 19
social impact